APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hay Fever and Allergic Rhinitis Decongestants Drug

Compare research editions
View pricing & licenses

Selected research

Industry Research

Hay Fever and Allergic Rhinitis Decongestants Drug Industry Research Report 2026

22 December 2025123 pages

Choose your research edition.

Industry ResearchHay Fever and Allergic Rhinitis Decongestants Drug Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Hay Fever and Allergic Rhinitis Decongestants Drug Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Hay Fever and Allergic Rhinitis Decongestants Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hay Fever and Allergic Rhinitis Decongestants Drug Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Hay Fever and Allergic Rhinitis Decongestants Drug Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Hay Fever and Allergic Rhinitis Decongestants Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Hay Fever and Allergic Rhinitis Decongestants Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Hay Fever and Allergic Rhinitis Decongestants Drug is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Hay Fever and Allergic Rhinitis Decongestants Drug is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Hay Fever and Allergic Rhinitis Decongestants Drug include Shenzhen Daphne, Johnson & Johnson, Nanjing Tianlang, Nanjing Haijing, Mingsheng Pharma, Dandong Pharma, Procter & Gamble, Bayer and Foundation Consumer Brands, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Hay Fever and Allergic Rhinitis Decongestants Drug market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Hay Fever and Allergic Rhinitis Decongestants Drug Market by Company

Shenzhen Daphne

Johnson & Johnson

Nanjing Tianlang

Nanjing Haijing

Mingsheng Pharma

Dandong Pharma

Procter & Gamble

Bayer

Foundation Consumer Brands

B.F. Ascher & Company

Hay Fever and Allergic Rhinitis Decongestants Drug Segment by Type

Nasal Spray

Tablet

Hay Fever and Allergic Rhinitis Decongestants Drug Segment by Application

Clinic

Hospital

Pharmacy Retail

Other

Hay Fever and Allergic Rhinitis Decongestants Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hay Fever and Allergic Rhinitis Decongestants Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hay Fever and Allergic Rhinitis Decongestants Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hay Fever and Allergic Rhinitis Decongestants Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Hay Fever and Allergic Rhinitis Decongestants Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Hay Fever and Allergic Rhinitis Decongestants Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Hay Fever and Allergic Rhinitis Decongestants Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Hay Fever and Allergic Rhinitis Decongestants Drug Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales (k units) of Manufacturers (2021-2026) Table 7. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Market Share by Manufacturers (2021-2026) Table 8. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue of Manufacturers (2021-2026) Table 9. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Hay Fever and Allergic Rhinitis Decongestants Drug Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Hay Fever and Allergic Rhinitis Decongestants Drug Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Hay Fever and Allergic Rhinitis Decongestants Drug, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Hay Fever and Allergic Rhinitis Decongestants Drug, Product Type & Application Table 14. Global Hay Fever and Allergic Rhinitis Decongestants Drug Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Hay Fever and Allergic Rhinitis Decongestants Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Shenzhen Daphne Company Information Table 19. Shenzhen Daphne Business Overview Table 20. Shenzhen Daphne Hay Fever and Allergic Rhinitis Decongestants Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Shenzhen Daphne Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio Table 22. Shenzhen Daphne Recent Developments Table 23. Johnson & Johnson Company Information Table 24. Johnson & Johnson Business Overview Table 25. Johnson & Johnson Hay Fever and Allergic Rhinitis Decongestants Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Johnson & Johnson Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio Table 27. Johnson & Johnson Recent Developments Table 28. Nanjing Tianlang Company Information Table 29. Nanjing Tianlang Business Overview Table 30. Nanjing Tianlang Hay Fever and Allergic Rhinitis Decongestants Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Nanjing Tianlang Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio Table 32. Nanjing Tianlang Recent Developments Table 33. Nanjing Haijing Company Information Table 34. Nanjing Haijing Business Overview Table 35. Nanjing Haijing Hay Fever and Allergic Rhinitis Decongestants Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Nanjing Haijing Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio Table 37. Nanjing Haijing Recent Developments Table 38. Mingsheng Pharma Company Information Table 39. Mingsheng Pharma Business Overview Table 40. Mingsheng Pharma Hay Fever and Allergic Rhinitis Decongestants Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. Mingsheng Pharma Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio Table 42. Mingsheng Pharma Recent Developments Table 43. Dandong Pharma Company Information Table 44. Dandong Pharma Business Overview Table 45. Dandong Pharma Hay Fever and Allergic Rhinitis Decongestants Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Dandong Pharma Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio Table 47. Dandong Pharma Recent Developments Table 48. Procter & Gamble Company Information Table 49. Procter & Gamble Business Overview Table 50. Procter & Gamble Hay Fever and Allergic Rhinitis Decongestants Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Procter & Gamble Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio Table 52. Procter & Gamble Recent Developments Table 53. Bayer Company Information Table 54. Bayer Business Overview Table 55. Bayer Hay Fever and Allergic Rhinitis Decongestants Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. Bayer Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio Table 57. Bayer Recent Developments Table 58. Foundation Consumer Brands Company Information Table 59. Foundation Consumer Brands Business Overview Table 60. Foundation Consumer Brands Hay Fever and Allergic Rhinitis Decongestants Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Foundation Consumer Brands Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio Table 62. Foundation Consumer Brands Recent Developments Table 63. B.F. Ascher & Company Company Information Table 64. B.F. Ascher & Company Business Overview Table 65. B.F. Ascher & Company Hay Fever and Allergic Rhinitis Decongestants Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. B.F. Ascher & Company Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio Table 67. B.F. Ascher & Company Recent Developments Table 68. Global Hay Fever and Allergic Rhinitis Decongestants Drug Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 69. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Region (2021-2026) & (k units) Table 70. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Market Share by Region (2021-2026) Table 71. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Region (2027-2032) & (k units) Table 72. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Market Share by Region (2027-2032) Table 73. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Region (2021-2026) & (US$ Million) Table 74. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Market Share by Region (2021-2026) Table 75. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Region (2027-2032) & (US$ Million) Table 76. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Market Share by Region (2027-2032) Table 77. North America Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 78. North America Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Country (2021-2026) & (k units) Table 79. North America Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Country (2027-2032) & (k units) Table 80. North America Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Country (2021-2026) & (US$ Million) Table 81. North America Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Country (2027-2032) & (US$ Million) Table 82. Europe Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. Europe Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Country (2021-2026) & (k units) Table 84. Europe Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Country (2027-2032) & (k units) Table 85. Europe Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Country (2021-2026) & (US$ Million) Table 86. Europe Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Country (2027-2032) & (US$ Million) Table 87. Asia Pacific Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. Asia Pacific Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Country (2021-2026) & (k units) Table 89. Asia Pacific Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Country (2027-2032) & (k units) Table 90. Asia Pacific Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Country (2021-2026) & (US$ Million) Table 91. Asia Pacific Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Country (2027-2032) & (US$ Million) Table 92. South America Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. South America Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Country (2021-2026) & (k units) Table 94. South America Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Country (2027-2032) & (k units) Table 95. South America Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Country (2021-2026) & (US$ Million) Table 96. South America Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Country (2027-2032) & (US$ Million) Table 97. Middle East and Africa Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Middle East and Africa Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Country (2021-2026) & (k units) Table 99. Middle East and Africa Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Country (2027-2032) & (k units) Table 100. Middle East and Africa Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Country (2021-2026) & (US$ Million) Table 101. Middle East and Africa Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Country (2027-2032) & (US$ Million) Table 102. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Type (2021-2026) & (k units) Table 103. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Type (2027-2032) & (k units) Table 104. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Market Share by Type (2021-2026) Table 105. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Market Share by Type (2027-2032) Table 106. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Type (2021-2026) & (US$ Million) Table 107. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Type (2027-2032) & (US$ Million) Table 108. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Market Share by Type (2021-2026) Table 109. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Market Share by Type (2027-2032) Table 110. Global Hay Fever and Allergic Rhinitis Decongestants Drug Price by Type (2021-2026) & (US$/unit) Table 111. Global Hay Fever and Allergic Rhinitis Decongestants Drug Price by Type (2027-2032) & (US$/unit) Table 112. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Application (2021-2026) & (k units) Table 113. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Application (2027-2032) & (k units) Table 114. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Market Share by Application (2021-2026) Table 115. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Market Share by Application (2027-2032) Table 116. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Application (2021-2026) & (US$ Million) Table 117. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Application (2027-2032) & (US$ Million) Table 118. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Market Share by Application (2021-2026) Table 119. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Market Share by Application (2027-2032) Table 120. Global Hay Fever and Allergic Rhinitis Decongestants Drug Price by Application (2021-2026) & (US$/unit) Table 121. Global Hay Fever and Allergic Rhinitis Decongestants Drug Price by Application (2027-2032) & (US$/unit) Table 122. Key Raw Materials Table 123. Raw Materials Key Suppliers Table 124. Hay Fever and Allergic Rhinitis Decongestants Drug Distributors List Table 125. Hay Fever and Allergic Rhinitis Decongestants Drug Customers List Table 126. Hay Fever and Allergic Rhinitis Decongestants Drug Industry Trends Table 127. Hay Fever and Allergic Rhinitis Decongestants Drug Industry Drivers Table 128. Hay Fever and Allergic Rhinitis Decongestants Drug Industry Restraints Table 129. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Hay Fever and Allergic Rhinitis Decongestants Drug Product Image Figure 5. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Hay Fever and Allergic Rhinitis Decongestants Drug Market Size (2021-2032) & (US$ Million) Figure 7. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales (2021-2032) & (k units) Figure 8. Global Hay Fever and Allergic Rhinitis Decongestants Drug Average Price (US$/unit) & (2021-2032) Figure 9. Nasal Spray Product Image Figure 10. Tablet Product Image Figure 11. Clinic Product Image Figure 12. Hospital Product Image Figure 13. Pharmacy Retail Product Image Figure 14. Other Product Image Figure 15. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Hay Fever and Allergic Rhinitis Decongestants Drug, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Hay Fever and Allergic Rhinitis Decongestants Drug Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Hay Fever and Allergic Rhinitis Decongestants Drug Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Region in 2025 Figure 21. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Region in 2025 Figure 22. North America Hay Fever and Allergic Rhinitis Decongestants Drug Market Size by Country in 2025 Figure 23. North America Hay Fever and Allergic Rhinitis Decongestants Drug Sales Market Share by Country (2021-2032) Figure 24. North America Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Market Share by Country (2021-2032) Figure 25. United States Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Mexico Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Europe Hay Fever and Allergic Rhinitis Decongestants Drug Market Size by Country in 2025 Figure 29. Europe Hay Fever and Allergic Rhinitis Decongestants Drug Sales Market Share by Country (2021-2032) Figure 30. Europe Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Market Share by Country (2021-2032) Figure 31. Germany Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. France Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. U.K. Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Italy Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Russia Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Spain Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Netherlands Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Switzerland Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Sweden Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Poland Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Asia Pacific Hay Fever and Allergic Rhinitis Decongestants Drug Market Size by Country in 2025 Figure 42. Asia Pacific Hay Fever and Allergic Rhinitis Decongestants Drug Sales Market Share by Country (2021-2032) Figure 43. Asia Pacific Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Market Share by Country (2021-2032) Figure 44. China Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Japan Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South Korea Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. India Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Australia Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Taiwan Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. South America Hay Fever and Allergic Rhinitis Decongestants Drug Market Size by Country in 2025 Figure 53. South America Hay Fever and Allergic Rhinitis Decongestants Drug Sales Market Share by Country (2021-2032) Figure 54. South America Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Market Share by Country (2021-2032) Figure 55. Brazil Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Argentina Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Chile Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Middle East and Africa Hay Fever and Allergic Rhinitis Decongestants Drug Market Size by Country in 2025 Figure 59. Middle East and Africa Hay Fever and Allergic Rhinitis Decongestants Drug Sales Market Share by Country (2021-2032) Figure 60. Middle East and Africa Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Market Share by Country (2021-2032) Figure 61. Egypt Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. South Africa Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Israel Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Türkiye Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. GCC Countries Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Market Share by Type (2021-2032) Figure 67. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Market Share by Type (2021-2032) Figure 68. Global Hay Fever and Allergic Rhinitis Decongestants Drug Price (US$/unit) by Type (2021-2032) Figure 69. Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Market Share by Application (2021-2032) Figure 70. Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Market Share by Application (2021-2032) Figure 71. Global Hay Fever and Allergic Rhinitis Decongestants Drug Price (US$/unit) by Application (2021-2032) Figure 72. Hay Fever and Allergic Rhinitis Decongestants Drug Value Chain Figure 73. Hay Fever and Allergic Rhinitis Decongestants Drug Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Hay Fever and Allergic Rhinitis Decongestants Drug Industry Opportunities and Challenges

Scope & coverage.

Types
  • Nasal Spray
  • Tablet
Applications
  • Clinic
  • Hospital
  • Pharmacy Retail
  • Other
Companies covered
  • Shenzhen Daphne
  • Johnson & Johnson
  • Nanjing Tianlang
  • Nanjing Haijing
  • Mingsheng Pharma
  • Dandong Pharma
  • Procter & Gamble
  • Bayer
  • Foundation Consumer Brands
  • B.F. Ascher & Company

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Hay Fever and Allergic Rhinitis Decongestants Drug Market Size (2021-2032)
  4. 2.2.2 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales (2021-2032)
  5. 2.2.3 Global Hay Fever and Allergic Rhinitis Decongestants Drug Market Average Price (2021-2032)
  6. 2.3 Hay Fever and Allergic Rhinitis Decongestants Drug by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Nasal Spray
  9. 2.3.3 Tablet
  10. 2.4 Hay Fever and Allergic Rhinitis Decongestants Drug by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Clinic
  13. 2.4.3 Hospital
  14. 2.4.4 Pharmacy Retail
  15. 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Hay Fever and Allergic Rhinitis Decongestants Drug Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Hay Fever and Allergic Rhinitis Decongestants Drug Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Hay Fever and Allergic Rhinitis Decongestants Drug Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Hay Fever and Allergic Rhinitis Decongestants Drug, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Hay Fever and Allergic Rhinitis Decongestants Drug, Product Type & Application
  8. 3.8 Global Manufacturers of Hay Fever and Allergic Rhinitis Decongestants Drug, Established Date
  9. 3.9 Global Hay Fever and Allergic Rhinitis Decongestants Drug Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Shenzhen Daphne
  2. 4.1.1 Shenzhen Daphne Company Information
  3. 4.1.2 Shenzhen Daphne Business Overview
  4. 4.1.3 Shenzhen Daphne Hay Fever and Allergic Rhinitis Decongestants Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Shenzhen Daphne Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio
  6. 4.1.5 Shenzhen Daphne Recent Developments
  7. 4.2 Johnson & Johnson
  8. 4.2.1 Johnson & Johnson Company Information
  9. 4.2.2 Johnson & Johnson Business Overview
  10. 4.2.3 Johnson & Johnson Hay Fever and Allergic Rhinitis Decongestants Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Johnson & Johnson Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio
  12. 4.2.5 Johnson & Johnson Recent Developments
  13. 4.3 Nanjing Tianlang
  14. 4.3.1 Nanjing Tianlang Company Information
  15. 4.3.2 Nanjing Tianlang Business Overview
  16. 4.3.3 Nanjing Tianlang Hay Fever and Allergic Rhinitis Decongestants Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Nanjing Tianlang Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio
  18. 4.3.5 Nanjing Tianlang Recent Developments
  19. 4.4 Nanjing Haijing
  20. 4.4.1 Nanjing Haijing Company Information
  21. 4.4.2 Nanjing Haijing Business Overview
  22. 4.4.3 Nanjing Haijing Hay Fever and Allergic Rhinitis Decongestants Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Nanjing Haijing Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio
  24. 4.4.5 Nanjing Haijing Recent Developments
  25. 4.5 Mingsheng Pharma
  26. 4.5.1 Mingsheng Pharma Company Information
  27. 4.5.2 Mingsheng Pharma Business Overview
  28. 4.5.3 Mingsheng Pharma Hay Fever and Allergic Rhinitis Decongestants Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Mingsheng Pharma Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio
  30. 4.5.5 Mingsheng Pharma Recent Developments
  31. 4.6 Dandong Pharma
  32. 4.6.1 Dandong Pharma Company Information
  33. 4.6.2 Dandong Pharma Business Overview
  34. 4.6.3 Dandong Pharma Hay Fever and Allergic Rhinitis Decongestants Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Dandong Pharma Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio
  36. 4.6.5 Dandong Pharma Recent Developments
  37. 4.7 Procter & Gamble
  38. 4.7.1 Procter & Gamble Company Information
  39. 4.7.2 Procter & Gamble Business Overview
  40. 4.7.3 Procter & Gamble Hay Fever and Allergic Rhinitis Decongestants Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Procter & Gamble Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio
  42. 4.7.5 Procter & Gamble Recent Developments
  43. 4.8 Bayer
  44. 4.8.1 Bayer Company Information
  45. 4.8.2 Bayer Business Overview
  46. 4.8.3 Bayer Hay Fever and Allergic Rhinitis Decongestants Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Bayer Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio
  48. 4.8.5 Bayer Recent Developments
  49. 4.9 Foundation Consumer Brands
  50. 4.9.1 Foundation Consumer Brands Company Information
  51. 4.9.2 Foundation Consumer Brands Business Overview
  52. 4.9.3 Foundation Consumer Brands Hay Fever and Allergic Rhinitis Decongestants Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Foundation Consumer Brands Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio
  54. 4.9.5 Foundation Consumer Brands Recent Developments
  55. 4.10 B.F. Ascher & Company
  56. 4.10.1 B.F. Ascher & Company Company Information
  57. 4.10.2 B.F. Ascher & Company Business Overview
  58. 4.10.3 B.F. Ascher & Company Hay Fever and Allergic Rhinitis Decongestants Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 B.F. Ascher & Company Hay Fever and Allergic Rhinitis Decongestants Drug Product Portfolio
  60. 4.10.5 B.F. Ascher & Company Recent Developments
5 Global Hay Fever and Allergic Rhinitis Decongestants Drug Market Scenario by Region
  1. 5.1 Global Hay Fever and Allergic Rhinitis Decongestants Drug Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Region: 2021-2032
  3. 5.2.1 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Region: 2021-2026
  4. 5.2.2 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Region: 2027-2032
  5. 5.3 Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Region: 2021-2032
  6. 5.3.1 Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Region: 2021-2026
  7. 5.3.2 Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Region: 2027-2032
  8. 5.4 North America Hay Fever and Allergic Rhinitis Decongestants Drug Market Facts & Figures by Country
  9. 5.4.1 North America Hay Fever and Allergic Rhinitis Decongestants Drug Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Country (2021-2032)
  11. 5.4.3 North America Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Hay Fever and Allergic Rhinitis Decongestants Drug Market Facts & Figures by Country
  16. 5.5.1 Europe Hay Fever and Allergic Rhinitis Decongestants Drug Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Country (2021-2032)
  18. 5.5.3 Europe Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Hay Fever and Allergic Rhinitis Decongestants Drug Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Hay Fever and Allergic Rhinitis Decongestants Drug Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Hay Fever and Allergic Rhinitis Decongestants Drug Market Facts & Figures by Country
  41. 5.7.1 South America Hay Fever and Allergic Rhinitis Decongestants Drug Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Country (2021-2032)
  43. 5.7.3 South America Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Hay Fever and Allergic Rhinitis Decongestants Drug Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Hay Fever and Allergic Rhinitis Decongestants Drug Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Type (2021-2032)
  2. 6.1.1 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Market Share by Type (2021-2032)
  4. 6.2 Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Type (2021-2032)
  5. 6.2.1 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Hay Fever and Allergic Rhinitis Decongestants Drug Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Application (2021-2032)
  2. 7.1.1 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales Market Share by Application (2021-2032)
  4. 7.2 Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue by Application (2021-2032)
  5. 7.2.1 Global Hay Fever and Allergic Rhinitis Decongestants Drug Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Hay Fever and Allergic Rhinitis Decongestants Drug Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Hay Fever and Allergic Rhinitis Decongestants Drug Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Hay Fever and Allergic Rhinitis Decongestants Drug Value Chain Analysis
  2. 8.1.1 Hay Fever and Allergic Rhinitis Decongestants Drug Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Hay Fever and Allergic Rhinitis Decongestants Drug Production Mode & Process
  5. 8.2 Hay Fever and Allergic Rhinitis Decongestants Drug Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Hay Fever and Allergic Rhinitis Decongestants Drug Distributors
  8. 8.2.3 Hay Fever and Allergic Rhinitis Decongestants Drug Customers
9 Global Hay Fever and Allergic Rhinitis Decongestants Drug Analyzing Market Dynamics
  1. 9.1 Hay Fever and Allergic Rhinitis Decongestants Drug Industry Trends
  2. 9.2 Hay Fever and Allergic Rhinitis Decongestants Drug Industry Drivers
  3. 9.3 Hay Fever and Allergic Rhinitis Decongestants Drug Industry Opportunities and Challenges
  4. 9.4 Hay Fever and Allergic Rhinitis Decongestants Drug Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst